Gaming the system: An overview of originator companies’ evergreening strategies used to hinder access to generic and biosimilar products

This report from the International Generic and Biosimilar Medicines Association looks at the various strategies used by some originator companies to extend monopolies of their medication products beyond the intended terms of a patent.